Log In
Print this Print this

OTX015, Y-803

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionSynthetic small molecule inhibitor of BET bromodomain containing 2 (BRD2), BRD3 and BRD4
Molecular Target Bromodomain containing 2 (BRD2) ; Bromodomain containing 3 (BRD3)
Mechanism of ActionBromodomain containing 2 (BRD2) inhibitor; Bromodomain containing 3 (BRD3) inhibitor; Bromodomain containing 4 (BRD4) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today